Europe — EMA
Odomzo (Sonidegib)
Sonidegib, the active ingredient in Odomzo, is a Hedgehog pathway inhibitor presented as a capsule for oral use. It treats locally advanced basal cell carcinoma in patients who are not candidates for surgery or…
Request sourcing
What is Sonidegib?
Sonidegib, the active ingredient in Odomzo, is a Hedgehog pathway inhibitor presented as a capsule for oral use. It treats locally advanced basal cell carcinoma in patients who are not candidates for surgery or radiation. GNH USA supplies Odomzo as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.
GNH USA supplies Odomzo as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.
What is Sonidegib used for?
Odomzo is a Hedgehog pathway‑targeted - Basal cell carcinoma: Provides t t t t - - - t
What are the side effects of Sonidegib?
Common
